Hofseth BioCare ASA

HBC

NO0010598683

Food Processing

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-07-16 EDT			5-day change	1st Jan Change
2.2 ^NOK	+6.28%		+7.32%	-16.03%

07-02	Hofseth BioCare to Transfer Patent for New Asthma Drug Candidate to Unit	MT
06-11	Hofseth Biocare ASA Announces the Appointment of Lithy One- Health Group Technology Co. Ltd as an Additional Distributor in China	CI

Hofseth BioCare ASA Reports Production and Revenue Results for the Fourth Quarter of 2017

January 11, 2018 at 08:06 am

Hofseth BioCare ASA reported production and revenue results for the fourth quarter of 2017. For the quarter, the company produced a total of 2,794 metric tons of raw material, compared to 2,241 in the third quarter 2017.

For the quarter, total revenues amounted to approx. NOK 26 million.

Latest news about Hofseth BioCare ASA

Hofseth BioCare to Transfer Patent for New Asthma Drug Candidate to Unit	07-02	MT
Hofseth Biocare ASA Announces the Appointment of Lithy One- Health Group Technology Co. Ltd as an Additional Distributor in China	06-11	CI
Hofseth BioCare ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	05-16	CI
Hofseth BioCare ASA Announces Board Changes	03-14	CI
Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-09	CI
Hofseth BioCare ASA Reports Earnings Results for the Full Year Ended December 31, 2023	02-09	CI
Hofseth BioCare ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-10	CI
Hofseth BioCare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25	CI
Hofseth BioCare Secures Seed Funding for Pre-clinical Study of Prostate Cancer Treatment	23-08-17	MT
Aqua Bio Technology Asa Announces Distribution Agreement with Hofseth Biocare Asa	23-07-12	CI
Hofseth Biocare ASA Announces the Online Publication of Its Abstract	23-05-29	CI
Norway’s Hofseth Biocare Moves Prostate Cancer Co-treatment Project to US Entity	23-05-15	MT
Hofseth BioCare ASA Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Hofseth BioCare ASA Auditor Raises 'Going Concern' Doubt	23-03-30	CI
Hofseth BioCare ASA Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-10	CI
Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-10	CI
Hofseth BioCare ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
Hofseth BioCare Says Preclinical Trial Shows ProGo Peptides Support Gut Health	22-10-17	MT
Hofseth BioCare ASA's Progo Bioactive Peptides Now Is A "New Dietary Ingredient" for the US FDA	22-08-28	CI
Hofseth BioCare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Hofseth Biocare Appoints CFO as CEO	22-07-29	MT
Hofseth BioCare ASA Announces Executive Changes	22-07-29	CI
Hofseth BioCare ASA announced that it has received NOK 1.4196 billion in funding	22-06-30	CI
Hofseth BioCare ASA Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-06	CI
Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-04	CI

Chart Hofseth BioCare ASA

Duration

Period

More charts

Company Profile

Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Companyâs business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

Sector

Food Processing

Calendar

2024-08-29 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Food Processing

	1st Jan change	Capi.
HOFSETH BIOCARE ASA	-16.03%	75.81M
NESTLÉ S.A.	-5.01%	273B
MONDELEZ INTERNATIONAL, INC.	-9.11%	86.32B
DANONE	-0.48%	41B
KRAFT HEINZ	-11.20%	39.21B
THE HERSHEY COMPANY	+1.89%	38.21B
GENERAL MILLS, INC.	-3.44%	35.09B
ARCHER-DANIELS-MIDLAND COMPANY	-10.61%	31.35B
NESTLÉ INDIA LIMITED	-1.97%	30.03B
ASSOCIATED BRITISH FOODS PLC	+4.10%	23.79B